Lyra Therapeutics, Inc. (LYRA)
Data as of , from SEC Form 4 filings.
See up to 3 months of LYRA. The 7-day demo opens the 1M and 3M ranges and puts LYRA on your watchlist.
Start 7-day demoLatest LYRA insider trades
About Lyra Therapeutics, Inc. (LYRA)
The SEC lists Lyra Therapeutics, Inc. under CIK 0001327273, in surgical and medical instruments and apparatus. It is grouped with Health Care companies on this site.
LYRA Form 4 activity by transaction type, last 90 days
No Form 4 activity for LYRA in the last 90 days.
LYRA insider transactions (Form 4)
2516 Form 4 filings on record, the earliest from Oct 18, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| W. Bradford Smith | Derivative | Common Stock | 640 | $0.00 | - | |
| Maria Palasis - Officer | Derivative | Common Stock | 2,000 | $0.00 | - | |
| Derivative | Common Stock | 667 | $0.00 | - | ||
| Open-market sale | Common Stock | 769 | $3.36 | $3K | ||
| Maria Palasis - Officer | Open-market sale | Common Stock | 1,702 | $3.36 | $6K | |
| PERCEPTIVE ADVISORS LLC | Open-market sale | Common Stock | 7,862 | $4.06 footnote F5 | $32K | |
| PERCEPTIVE ADVISORS LLC | Open-market sale | Common Stock | 883 | $4.06 footnote F5 | $4K | |
| PERCEPTIVE ADVISORS LLC | Open-market sale | Common Stock | 28,597 | $3.90 footnote F6 | $112K | |
| PERCEPTIVE ADVISORS LLC | Open-market sale | Common Stock | 3,213 | $3.90 footnote F6 | $13K | |
| PERCEPTIVE ADVISORS LLC | Open-market sale | Common Stock | 4,783 | $4.31 footnote F1 | $21K | |
| PERCEPTIVE ADVISORS LLC | Open-market sale | Common Stock | 537 | $4.31 footnote F1 | $2K | |
| ||||||
| PERCEPTIVE ADVISORS LLC | Open-market sale | Common Stock | 3,247 | $5.18 footnote F1 | $17K | |
| PERCEPTIVE ADVISORS LLC | Open-market sale | Common Stock | 17,746 | $4.75 footnote F5 | $84K | |
| PERCEPTIVE ADVISORS LLC | Open-market sale | Common Stock | 1,993 | $4.75 footnote F5 | $9K | |
| PERCEPTIVE ADVISORS LLC | Open-market sale | Common Stock | 16,633 | $4.54 footnote F6 | $76K | |
| PERCEPTIVE ADVISORS LLC | Open-market sale | Common Stock | 1,869 | $4.54 footnote F6 | $8K | |
| PERCEPTIVE ADVISORS LLC | Open-market sale | Common Stock | 28,902 | $5.18 footnote F1 | $150K | |
| ||||||
| Open-market sale | Common Stock | 684 | $8.91 | $6K | ||
| Maria Palasis - Officer | Open-market sale | Common Stock | 1,565 | $8.91 | $14K | |
| C. Ann Merrifield | Grant or award | Restricted Stock Units | 32,000 | $0.00 | - | |
| James R. Tobin | Grant or award | Restricted Stock Units | 32,000 | $0.00 | - | |
| Maria Palasis - Officer | Grant or award | Employee Stock Option (right to buy) | 183,333 | $0.00 | - | |
| Harlan Waksal - Officer | Grant or award | Performance-based Restricted Stock Units | 128,333 | $0.00 | - | |
| Maria Palasis - Officer | Grant or award | Common Stock | 300,000 | $0.00 | - | |
| Grant or award | Common Stock | 100,000 | $0.00 | - | ||
LYRA insider trading FAQ
What is the latest insider trade for LYRA?
Lyra Therapeutics, Inc. (LYRA) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-05-15. The full record for LYRA runs to 16 Form 4 filings, the earliest from 2024-10-18. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying LYRA stock?
No insider purchases of LYRA were filed in the last 90 days.
How many insiders are selling LYRA stock?
No insider sales of LYRA were filed in the last 90 days. 16 sales are on record for this company.
Where can I see LYRA SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects LYRA Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - W. Bradford Smith view on EDGAR
- - Maria Palasis view on EDGAR
- - Jason Cavalier view on EDGAR
- - Jason Cavalier view on EDGAR
- - Maria Palasis view on EDGAR
- - PERCEPTIVE ADVISORS LLC view on EDGAR
- - PERCEPTIVE ADVISORS LLC view on EDGAR
- - Maria Palasis view on EDGAR
- - Jason Cavalier view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where LYRA's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow LYRA with a 7-day demo
- LYRA on your watchlist
- Every LYRA Form 4 filing on record
- Up to 3 months of LYRA price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive